BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 27005822)

  • 1. CAST your vote: is calpain inhibition the answer to ALS?
    Wright AL; Vissel B
    J Neurochem; 2016 Apr; 137(2):140-1. PubMed ID: 27005822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calpastatin inhibits motor neuron death and increases survival of hSOD1(G93A) mice.
    Rao MV; Campbell J; Palaniappan A; Kumar A; Nixon RA
    J Neurochem; 2016 Apr; 137(2):253-65. PubMed ID: 26756888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calpastatin reduces toxicity of SOD1G93A in a culture model of amyotrophic lateral sclerosis.
    Tradewell ML; Durham HD
    Neuroreport; 2010 Oct; 21(15):976-9. PubMed ID: 20736867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XIAP decreases caspase-12 cleavage and calpain activity in spinal cord of ALS transgenic mice.
    Wootz H; Hansson I; Korhonen L; Lindholm D
    Exp Cell Res; 2006 Jun; 312(10):1890-8. PubMed ID: 16566922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of human mutated G93A SOD1 changes dynamics of the ER mitochondria calcium cycle specifically in mouse embryonic motor neurons.
    Lautenschläger J; Prell T; Ruhmer J; Weidemann L; Witte OW; Grosskreutz J
    Exp Neurol; 2013 Sep; 247():91-100. PubMed ID: 23578819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calpain activation and CaMKIV reduction in spinal cords from hSOD1G93A mouse model.
    Gou-Fabregas M; Ramírez-Núñez O; Cacabelos D; Bahi N; Portero M; Garcera A; Soler RM
    Mol Cell Neurosci; 2014 Jul; 61():219-25. PubMed ID: 25063475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TDP-43 modification in the hSOD1(G93A) amyotrophic lateral sclerosis mouse model.
    Cai M; Lee KW; Choi SM; Yang EJ
    Neurol Res; 2015 Mar; 37(3):253-62. PubMed ID: 25213598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetyl-L-tryptophan delays disease onset and extends survival in an amyotrophic lateral sclerosis transgenic mouse model.
    Li W; Fotinos A; Wu Q; Chen Y; Zhu Y; Baranov S; Tu Y; Zhou EW; Sinha B; Kristal BS; Wang X
    Neurobiol Dis; 2015 Aug; 80():93-103. PubMed ID: 25986728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
    Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
    J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Lee JY; Lee JD; Phipps S; Noakes PG; Woodruff TM
    J Neuroinflammation; 2015 May; 12():90. PubMed ID: 25962427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of chronic glutamate-mediated motor neuron toxicity in organotypic spinal cord culture prepared from ALS model mice.
    Kosuge Y; Sekikawa-Nishida K; Negi H; Ishige K; Ito Y
    Neurosci Lett; 2009 Apr; 454(2):165-9. PubMed ID: 19429077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of resveratrol through the up-regulation of SIRT1 expression in the mutant hSOD1-G93A-bearing motor neuron-like cell culture model of amyotrophic lateral sclerosis.
    Wang J; Zhang Y; Tang L; Zhang N; Fan D
    Neurosci Lett; 2011 Oct; 503(3):250-5. PubMed ID: 21896316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human superoxide dismutase 1 overexpression in motor neurons of Caenorhabditis elegans causes axon guidance defect and neurodegeneration.
    Li J; Li T; Zhang X; Tang Y; Yang J; Le W
    Neurobiol Aging; 2014 Apr; 35(4):837-46. PubMed ID: 24126158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin-1 is over-expressed in amyotrophic lateral sclerosis and induces motor neuron cell death.
    Ranno E; D'Antoni S; Spatuzza M; Berretta A; Laureanti F; Bonaccorso CM; Pellitteri R; Longone P; Spalloni A; Iyer AM; Aronica E; Catania MV
    Neurobiol Dis; 2014 May; 65():160-71. PubMed ID: 24423643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairments to the GH-IGF-I axis in hSOD1G93A mice give insight into possible mechanisms of GH dysregulation in patients with amyotrophic lateral sclerosis.
    Steyn FJ; Ngo ST; Lee JD; Leong JW; Buckley AJ; Veldhuis JD; McCombe PA; Chen C; Bellingham MC
    Endocrinology; 2012 Aug; 153(8):3735-46. PubMed ID: 22621959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of GSK-3beta activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene.
    Koh SH; Lee YB; Kim KS; Kim HJ; Kim M; Lee YJ; Kim J; Lee KW; Kim SH
    Eur J Neurosci; 2005 Jul; 22(2):301-9. PubMed ID: 16045483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.